WallStreetZenWallStreetZen

NYSEMKT: OCX
ONCOCYTE CORP Stock Ownership - Who owns ONCOCYTE?

Buy OCX

Insider buying vs selling

Have ONCOCYTE CORP insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Li YuVP CntrllrPrncpl Acctng Offcr2022-05-188,128$1.14
$9.27kSell
Broadwood Partners LP10% Owner2022-04-146,003,752$1.33
$8.00MBuy
Pura Vida Investments LLC10% Owner2022-04-141,381,438$1.33
$1.84MBuy
Pura Vida Investments LLC10% Owner2022-04-1492,370$1.26
$116.39kBuy
Pura Vida Investments LLC10% Owner2022-04-141,916,419$1.33
$2.55MBuy
Pura Vida Investments LLC10% Owner2022-04-1419,210$1.23
$23.57kBuy
Pura Vida Investments LLC10% Owner2022-04-1457,630$1.26
$72.61kBuy
Pura Vida Investments LLC10% Owner2022-04-14767,952$1.33
$1.02MBuy
Pura Vida Investments LLC10% Owner2022-04-141,381,438$1.33
$1.84MBuy
Pura Vida Investments LLC10% Owner2022-04-141,665,898$1.33
$2.22MBuy

1 of 3

OCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

OCX Shareholders

What type of owners hold ONCOCYTE CORP stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Broadwood Partners LP32.13%38,073,046$38.83MInsider
Pura Vida Investments LLC25.63%30,379,613$30.99MInsider
Broadwood Capital Inc14.64%17,349,945$17.70MInstitution
Pura Vida Investments LLC10.31%12,223,953$12.47MInstitution
Lineage Cell Therapeutics Inc5.10%6,041,154$6.16MInsider
Blackrock Inc4.16%4,933,649$5.03MInstitution
Vanguard Group Inc3.36%3,986,270$4.07MInstitution
George Karfunkel3.09%3,659,860$3.73MInsider
Orbimed Advisors LLC2.95%3,493,800$3.56MInstitution
Defender Capital LLC2.16%2,562,130$2.61MInstitution

1 of 3

OCX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCX40.51%59.49%Net BuyingNet Buying
ARMP1.63%98.37%Net BuyingNet Buying
CFRX52.30%47.70%
SRZN36.24%63.76%
ATNM5.60%94.40%

ONCOCYTE Stock Ownership FAQ

Who owns ONCOCYTE?

ONCOCYTE (NYSEMKT: OCX) is owned by 45.82% institutional shareholders, 67.29% ONCOCYTE insiders, and 0.00% retail investors. Broadwood Partners LP is the largest individual ONCOCYTE shareholder, owning 38.07M shares representing 32.13% of the company. Broadwood Partners LP's ONCOCYTE shares are currently valued at $38.83M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.